Alpha DNA Investment Management’s iShares MBS ETF MBB Stock Holding History

Alpha DNA Investment Management’s Portfolio MBB Stock Details MBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-150	Closed	-$16K	–	409
2021 Q1	$16K	Sell	150 -81	-35%	-$8.87K	0.02%	264
2020 Q4	$25K	Buy	+231	New	+$25.4K	0.03%	240

Other funds holding MBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.9% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Alpha DNA Investment Management's MBB Position: Q2 2021 in Review

Alpha DNA Investment Management sold out of iShares MBS ETF (MBB) in Q2 2021, closing a stake of 150 shares — an estimated $16K sold.

Alpha DNA Investment Management first reported a position in MBB in Q4 2020 and held it in 2 quarters. The position peaked at $25K in Q4 2020. 672 funds tracked by Wall St. Rank hold MBB as of Q2 2021.

Alpha DNA Investment Management reported no remaining iShares MBS ETF position as of Q2 2021 after selling out during the quarter.
Alpha DNA Investment Management sold 150 iShares MBS ETF shares in Q2 2021, an estimated $16K.
Alpha DNA Investment Management first reported a position in iShares MBS ETF in Q4 2020 and held it in 2 quarters.
Alpha DNA Investment Management's iShares MBS ETF position peaked at $25K in Q4 2020.
672 funds tracked by Wall St. Rank held iShares MBS ETF as of Q2 2021.

Based on Alpha DNA Investment Management's 13F filing for Q2 2021, filed 10 Aug 2021.